These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16283682)

  • 21. Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
    Tsuchiya Y; Lansky AJ; Costa RA; Mehran R; Pietras C; Shimada Y; Sonoda S; Cristea E; Negoita M; Dangas GD; Moses JW; Leon MB; Fitzgerald PJ; Müller R; Störger H; Hauptmann KE; Grube E
    Am J Cardiol; 2006 Aug; 98(4):464-9. PubMed ID: 16893698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trial.
    Tsuchida K; García-García HM; Ong AT; Valgimigli M; Aoki J; Rademaker TA; Morel MA; van Es GA; Bruining N; Serruys PW
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):188-97. PubMed ID: 16400664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirolimus-eluting cobalt alloyed stents in treating patients with coronary artery disease: six-month angiographic and one-year clinical follow-up result. A prospective, historically controlled, multi-center clinical study.
    Zhang Q; Xu B; Yang YJ; Zhang RY; Li JP; Qiao SB; Zhang JS; Hu J; Qin XW; Hong T; Chen JL; Huo Y; Shen WF; Gao RL
    Chin Med J (Engl); 2007 Apr; 120(7):533-8. PubMed ID: 17442198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
    Agostoni P; Vermeersch P; Semeraro O; Verheye S; Van Langenhove G; Van den Heuvel P; Convens C; Van den Branden F; Bruining N
    Am J Cardiol; 2007 Jul; 100(1):52-8. PubMed ID: 17599440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.
    Hur SH; Ako J; Shimada Y; Tsujino I; Hassan AH; Abizaid A; Shiran A; Lewis BS; Guagliumi G; Cohen SA; Honda Y; Fitzgerald PJ; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):411-6. PubMed ID: 18688066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nine-month angiographic and intravascular ultrasound outcomes after resolute zotarolimus-eluting stent implantation for the treatment of in-stent restenosis.
    Lee SY; Kim BK; Kim JS; Hong MK; Cho DK; Yoon J; Jeon DW; Lee NH; Kwon HM; Jang Y
    J Interv Cardiol; 2013 Dec; 26(6):543-9. PubMed ID: 24308658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
    Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
    JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial intravascular ultrasonic study of outcomes of coronary culprit lesions with plaque rupture following bare metal stent implantation in patients with angina pectoris.
    Hur SH; Hassan AH; Rekhi R; Ako J; Shimada Y; Nakamura M; Yamasaki M; Bonneau HN; Sudhir K; Yock PG; Honda Y; Fitzgerald PJ
    Am J Cardiol; 2007 May; 99(10):1394-8. PubMed ID: 17493467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.
    Rodriguez AE; Granada JF; Rodriguez-Alemparte M; Vigo CF; Delgado J; Fernandez-Pereira C; Pocovi A; Rodriguez-Granillo AM; Schulz D; Raizner AE; Palacios I; O'Neill W; Kaluza GL; Stone G;
    J Am Coll Cardiol; 2006 Apr; 47(8):1522-9. PubMed ID: 16630986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
    Sousa JE; Costa MA; Abizaid A; Abizaid AS; Feres F; Pinto IM; Seixas AC; Staico R; Mattos LA; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2001 Jan; 103(2):192-5. PubMed ID: 11208675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents.
    Hoffmann R; Stellbrink E; Schröder J; Grawe A; Vogel G; Blindt R; Kelm M; Radke PW
    Am J Cardiol; 2007 Nov; 100(9):1347-52. PubMed ID: 17950788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents.
    Muñoz JS; Abizaid A; Mintz GS; Albertal M; Abizaid AS; Feres F; Centemero M; Staico R; Mattos LA; Pinto I; Sousa A; Sousa JE
    Am J Cardiol; 2004 Feb; 93(4):470-3. PubMed ID: 14969627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension.
    Nakamura M; Abizaid A; Hirohata A; Honda Y; Sousa JE; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):946-51. PubMed ID: 17621671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.
    Mehilli J; Dibra A; Kastrati A; Pache J; Dirschinger J; Schömig A;
    Eur Heart J; 2006 Feb; 27(3):260-6. PubMed ID: 16401670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population].
    Bellandi F; Toso A; Maioli M; Leoncini M; Dabizzi RP
    Ital Heart J Suppl; 2005 Sep; 6(9):599-603. PubMed ID: 16281719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.